202 related articles for article (PubMed ID: 3931316)
21. Suppression of kidney allograft rejection across full MHC barriers by recipient-specific antibodies to class II MHC antigens.
Priestley CA; Spencer SC; Sawyer GJ; Fabre JW
Transplantation; 1992 May; 53(5):1024-32. PubMed ID: 1585464
[TBL] [Abstract][Full Text] [Related]
22. Humoral immunity to heterotopic corneal allografts in the rat.
Treseler PA; Sanfilippo F
Transplantation; 1985 Feb; 39(2):193-6. PubMed ID: 3881856
[TBL] [Abstract][Full Text] [Related]
23. Examination of serum class I antigen in allograft recipient rats--origin and control of serum class I antigen.
Sumimoto R; Fukuda Y; Shinomiya T; Asahara T; Dohi K
Hiroshima J Med Sci; 1998 Jun; 47(2):39-45. PubMed ID: 9674339
[TBL] [Abstract][Full Text] [Related]
24. Role of classical (RT1.A) and nonclassical (RT1.C) MHC class I regions in natural killer cell-mediated bone marrow allograft rejection in rats.
Engh E; Benestad HB; Strøm-Gundersen I; Vaage JT; Bell EB; Rolstad B
Transplantation; 1998 Feb; 65(3):319-24. PubMed ID: 9484746
[TBL] [Abstract][Full Text] [Related]
25. The new recombinant haplotypes r19 and r20 in RT1, the MHC of the rat.
Stephenson SP; Butcher GW
Transplantation; 1984 Jul; 38(1):71-5. PubMed ID: 6234687
[TBL] [Abstract][Full Text] [Related]
26. The cellular basis of cardiac allograft rejection: VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient rats.
Merten S; Chen JC; Ha H; Plain K; Boyd RA; Penny MJ; Leenaerts P; Hall BM
Transplantation; 1998 May; 65(9):1152-8. PubMed ID: 9603160
[TBL] [Abstract][Full Text] [Related]
27. Class I and class II regions of the major histocompatibility complex both contribute to individual odors in congenic inbred strains of rats.
Brown RE; Roser B; Singh PB
Behav Genet; 1989 Sep; 19(5):659-74. PubMed ID: 2508616
[TBL] [Abstract][Full Text] [Related]
28. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection.
Wood KJ; Hopley A; Dallman MJ; Morris PJ
Transplantation; 1988 Apr; 45(4):759-67. PubMed ID: 3282359
[TBL] [Abstract][Full Text] [Related]
29. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
[TBL] [Abstract][Full Text] [Related]
30. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
Yang CP; Shittu E; Bell EB
J Immunol; 2000 Mar; 164(5):2427-32. PubMed ID: 10679079
[TBL] [Abstract][Full Text] [Related]
31. Immune responses to noninherited maternal RT1A antigens in inbred rats.
Propper DJ; Woo J; Stewart KN; Catto GR; Power DA
Transplantation; 1991 Aug; 52(2):331-5. PubMed ID: 1871807
[TBL] [Abstract][Full Text] [Related]
32. Morphologic studies of acute rat cardiac allograft rejection across an isolated major histocompatibility complex class I (RT1A) disparity.
Forbes RD; Lowry RP; Darden AG; Gomersall M; Marghesco DM
Transplantation; 1988 May; 45(5):943-8. PubMed ID: 3285541
[TBL] [Abstract][Full Text] [Related]
33. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
[TBL] [Abstract][Full Text] [Related]
34. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody.
Sumimoto R; Kamada N
Transplantation; 1990 Oct; 50(4):678-82. PubMed ID: 2219291
[TBL] [Abstract][Full Text] [Related]
35. Major-histocompatibility-complex-restricted male skin graft rejection responses in rats.
Miyamoto M; Sano T; Suzuki K; Fukumoto T
Transplantation; 1984 Sep; 38(3):284-7. PubMed ID: 6382716
[TBL] [Abstract][Full Text] [Related]
36. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
[TBL] [Abstract][Full Text] [Related]
37. A detailed analysis of the potential of water-soluble classical class I MHC molecules for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses.
Priestley CA; Dalchau R; Sawyer GJ; Fabre JW
Transplantation; 1989 Dec; 48(6):1031-8. PubMed ID: 2595764
[TBL] [Abstract][Full Text] [Related]
38. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
Wasowska B; Baldwin WM; Sanfilippo F
Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
[TBL] [Abstract][Full Text] [Related]
39. Contributions of donor and host blood vessels in CNS allografts.
Baker-Cairns BJ; Sloan DJ; Broadwell RD; Puklavec M; Charlton HM
Exp Neurol; 1996 Nov; 142(1):36-46. PubMed ID: 8912897
[TBL] [Abstract][Full Text] [Related]
40. Certain host-donor strain combinations do not reject brain allografts after systemic sensitization.
Isono M; Poltorak M; Kulaga H; Adams AJ; Freed WJ
Exp Neurol; 1993 Jul; 122(1):48-56. PubMed ID: 8339789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
